Management of Paget's disease of bone

被引:74
|
作者
Langston, AL
Ralston, SH [1 ]
机构
[1] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
[2] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland
关键词
Paget's disease; bone; management; bisphosphonate; calcitonin;
D O I
10.1093/rheumatology/keh243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paget's disease of bone is a common condition with a strong genetic component, characterized by focal increases in bone turnover, affecting one or more bones throughout the skeleton. Paget's disease can be asymptomatic but is frequently associated with bone pain, bone deformity, pathological fracture, secondary osteoarthritis and deafness. Inhibitors of osteoclastic bone resorption, such as bisphosphonates and calcitonin, suppress bone turnover and improve bone pain in Paget's disease. Many patients also require therapy with analgesics and anti-inflammatory agents, since pain in Paget's disease can arise not only from increased bone turnover but also from complications such as osteoarthritis and nerve compression syndromes, which do not respond well to antiresorptive therapy. Comparative studies have shown that second- and third-generation bisphosphonates, such as tiludronate, alendronate and risedronate, are more effective than etidronate at inhibiting bone turnover in Paget's disease but they have not been found to be significantly more effective in controlling bone pain. Importantly, none of the treatments that are currently available for Paget's disease have been shown to prevent complications such as deafness, fracture or bone deformity, or to alter the natural history of the disease. More research is required to define the long-term effects of antiresorptive treatment on clinical outcomes in Paget's disease, so that clinicians and their patients can make better-informed choices about the risks and benefits of treatment.
引用
收藏
页码:955 / 959
页数:5
相关论文
共 50 条
  • [21] Paget’s Disease of Bone
    Luigi Gennari
    Domenico Rendina
    Alberto Falchetti
    Daniela Merlotti
    Calcified Tissue International, 2019, 104 : 483 - 500
  • [22] Paget's disease of bone
    Eslava, Torrijos A.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2014, 6 (04) : 77 - 78
  • [23] Paget's disease of bone
    Tan, A.
    Ralston, S. H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (11) : 865 - 869
  • [24] Paget's disease of bone
    Cundy, Tim
    Reid, Ian R.
    CLINICAL BIOCHEMISTRY, 2012, 45 (1-2) : 43 - 48
  • [25] Paget's disease of bone
    Pishdad, Reza
    Moseley, Kendall F.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (33) : E1138 - E1138
  • [26] Paget's disease of bone
    Appelman-Dijkstra, Natasha M.
    Papapoulos, Socrates E.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 32 (05) : 657 - 668
  • [27] Paget's disease of bone
    Thomas, P
    Howarth, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03): : 160 - 160
  • [28] Paget's disease of bone
    Cundy, Tim
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 80 : 5 - 14
  • [29] Paget's disease of bone
    Ooi, CG
    Fraser, WD
    POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (856) : 69 - 74
  • [30] Paget's disease of bone
    Walsh, JP
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (05) : 262 - 265